Grove Collaborative Holdings, Inc. (GROV) reported board changes effective August 27, 2026. Director Naytri Shroff Sramek resigned from the board, where she chaired the Sustainability, Nominating and Governance Committee and served on the Audit Committee. The company states there were no disagreements regarding operations, policies, or practices and no written statement accompanying her resignation.
The board appointed Jason Karp as a Class III director with a term expiring at the 2028 annual meeting of shareholders and determined he qualifies as an independent director under New York Stock Exchange listing standards. Karp brings experience founding and leading consumer and health-focused businesses and investment funds. He will enter into the company’s standard indemnification agreement and will not receive compensation for board service. Director John Replogle was appointed to the Audit Committee to replace Sramek, and the Sustainability, Nominating and Governance Committee was reduced from three to two directors.
Grove Collaborative Holdings, Inc. (symbol: GROV) is the issuer of record for a Form 4 filing submitted to the SEC.
Grove Collaborative Holdings, Inc. (symbol: GROV) is the issuer of record for a Form 4 filing submitted to the SEC.
Grove Collaborative Holdings, Inc. (symbol: GROV) is the issuer of record for a Form 4 filing submitted to the SEC.
Grove Collaborative Holdings, Inc. (symbol: GROV) is the issuer of record for a Form 4 filing submitted to the SEC.
Grove Collaborative Holdings, Inc. (GROV) reported multiple equity award transactions for Chief Legal Officer and Secretary Gary Scott Giesler on August 15, 2026. Several Restricted Stock Units converted into an aggregate of Class A Common Stock, and the company withheld a portion of the newly issued shares to cover associated tax withholding obligations at a reported price of $1.03 per share. The RSU footnotes describe quarterly vesting schedules beginning in 2025 and 2026 and clarify that each RSU represents a contingent right to receive one share of Class A Common Stock and that the RSUs have no expiration date.
Grove Collaborative Holdings, Inc. (GROV) reports that officer Gary Scott Giesler holds 38,320 Restricted Stock Units (RSUs), each representing one share of Class A Common Stock. Footnotes state that 40% of the shares subject to this RSU award vested on February 15, 2025, with 10% vesting on each standard quarterly vesting date thereafter beginning May 15, 2025. The RSUs have no expiration date. The reported amount reflects a 120‑share increase compared with the number of shares previously reported on the original Form 3.
Grove Collaborative Holdings, Inc. (GROV) reported that CFO Thomas Siragusa had multiple restricted stock unit (RSU) vesting and conversion events on August 15, 2026. RSUs converted into shares of Class A Common Stock, and a portion of the resulting shares was withheld by the company to cover tax withholding obligations at a per-share value of $1.03. Footnotes state that each RSU represents a right to receive one Class A share, that the amounts withheld were not in excess of the related tax liabilities, and they describe quarterly vesting schedules through August 15, 2026, including provisions for accelerated vesting following a change in control under certain termination conditions.
Grove Collaborative Holdings, Inc. (GROV) reported that President & CEO Jeffrey Michael Yurcisin exercised and settled restricted stock units (RSUs) into Class A Common Stock on August 15, 2026. A total of 101,420 RSUs, each representing one share of Class A Common Stock, were converted into an equal number of shares as scheduled vesting installments under multiple RSU awards. In connection with these vestings, the company withheld 24,697 shares of Class A Common Stock at $1.03 per share to satisfy Mr. Yurcisin’s tax withholding obligations, with the amount retained stated as not in excess of the related tax liability.
Grove Collaborative Holdings, Inc. reported that on August 7, 2026 it received a notice from the New York Stock Exchange stating that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual, which requires an average global market capitalization of at least $50 million over a consecutive 30 trading-day period and stockholders’ equity of at least $50 million. The company must submit a business plan within 45 days showing how it expects to regain compliance within a nine‑month Cure Period. The notice has no immediate impact on the listing of Grove’s Class A common stock, and the shares are expected to continue trading on the NYSE while the company prepares and submits its plan, subject to ongoing compliance with other NYSE continued listing standards. If Grove does not submit an acceptable plan, the NYSE could initiate delisting proceedings.